Preliminary Investigation and Therapeutic Efficacy Determination of a Novel Anti-IL-17A Antibody, Indikizumab.

Patra AK, Nayak S, Moharana A, Ojha P, Das SK, Akhtar J, Giri B, Singh S

Open source

DOI
10.2147/btt.s477752
Published
2024
Container
Biologics : targets & therapy
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/btt.s477752,
  title = {Preliminary Investigation and Therapeutic Efficacy Determination of a Novel Anti-IL-17A Antibody, Indikizumab.},
  author = {Patra AK and Nayak S and Moharana A and Ojha P and Das SK and Akhtar J and Giri B and Singh S},
  year = {2024},
  journal = {Biologics : targets \& therapy},
  doi = {10.2147/btt.s477752},
  url = {https://doi.org/10.2147/btt.s477752}
}

RIS

TY  - JOUR
TI  - Preliminary Investigation and Therapeutic Efficacy Determination of a Novel Anti-IL-17A Antibody, Indikizumab.
AU  - Patra AK
AU  - Nayak S
AU  - Moharana A
AU  - Ojha P
AU  - Das SK
AU  - Akhtar J
AU  - Giri B
AU  - Singh S
PY  - 2024
JO  - Biologics : targets & therapy
DO  - 10.2147/btt.s477752
UR  - https://doi.org/10.2147/btt.s477752
ER  - 

APA

AK, P., S, N., A, M., P, O., SK, D., J, A., B, G., & S, S. (2024). Preliminary Investigation and Therapeutic Efficacy Determination of a Novel Anti-IL-17A Antibody, Indikizumab.. Biologics : targets & therapy. https://doi.org/10.2147/btt.s477752

Source records